Updated Jul 16, 2026
Scott Kathleen D. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $388K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | DRMA | Dermata Therapeutics, Inc. | S — Open-market sale | 11 | $1.19 | $13 |
| 2025-08-21 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale | 12.5K | $15.00 | $188K |
| 2025-08-21 | SPRY | ARS Pharmaceuticals, Inc. | M — Option exercise | 12.5K | $1.50 | $19K |
| 2024-10-17 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 12.5K | $16.00 | $200K |
| 2024-10-17 | SPRY | ARS Pharmaceuticals, Inc. | M — Option exercise [10b5-1] | 12.5K | $1.50 | $19K |
Scott Kathleen D. is a corporate insider — currently tracked as Director of Dermata Therapeutics, Inc. (DRMA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($388K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Scott Kathleen D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.